LIQUID CALCIUM 132 MG
CALCIUM GLUCOHEPTONATE : 132 MG CALCIUM GLUCONATE : 112 MG · DIN 02230646 · WAMPOLE BRANDS, A DIVISION OF PANGEO PHARMA (CANADA) INC.
Health Canada status: CANCELLED POST MARKET
What is LIQUID CALCIUM?
LIQUID CALCIUM 132 MG contains CALCIUM GLUCOHEPTONATE : 132 MG CALCIUM GLUCONATE : 112 MG. It is listed in the Health Canada Drug Product Database under DIN 02230646, held by WAMPOLE BRANDS, A DIVISION OF PANGEO PHARMA (CANADA) INC., supplied as LIQUID for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 06-Jul-2000. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02230646 |
|---|---|
| Brand name | LIQUID CALCIUM |
| Generic / active ingredient | CALCIUM GLUCOHEPTONATE : 132 MG CALCIUM GLUCONATE : 112 MG |
| Manufacturer | WAMPOLE BRANDS, A DIVISION OF PANGEO PHARMA (CANADA) INC. |
| Strength | 132 MG |
| Dosage form | LIQUID |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A12AA20 CALCIUM (DIFFERENT SALTS IN COMBINATION) |
| AHFS class | 88:28.01* ; See footnote |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 06-Jul-2000 |
| Original market date | 1998-08-12 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02230646 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2230646 |
| Brand name | LIQUID CALCIUM |
| Active ingredient / INN | CALCIUM GLUCOHEPTONATE : 132 MG CALCIUM GLUCONATE : 112 MG |
| ATC code | A12AA20 |
| ATC anatomical main group | A — Alimentary tract and metabolism |
| ATC therapeutic subgroup | A12 |
| AHFS class | 88:28.01* ; See footnote |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| Biosimilar biologic | No |
| Market authorization holder | WAMPOLE BRANDS, A DIVISION OF PANGEO PHARMA (CANADA) INC. |
Which pack is which?
| Strength on the label | 132 MG |
|---|---|
| Dosage form | LIQUID |
| Route | ORAL |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Is CALCIUM (DIFFERENT SALTS IN COMBINATION) in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Anticipated — reported by PFIZER CANADA ULC, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code A12AA20 CALCIUM (DIFFERENT SALTS IN COMBINATION). 0 of 20 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| CALCIUM 500MG | 500 MG | TABLET | WN PHARMACEUTICALS LTD. | CANCELLED POST MARKET | DIN 02240977 |
| CALCIUM 650MG TAB | 650 MG | TABLET | JAMIESON LABORATORIES LTD | CANCELLED POST MARKET | DIN 02040913 |
| CALCIUM CITRAMATE | 160.0 MG | CAPSULE | THORNE RESEARCH INC. | CANCELLED POST MARKET | DIN 02080222 |
| CALCIUM INJ | 10 MG | LIQUID | KRIPPS PHARMACY LTD. | DORMANT | DIN 00532762 |
| CALCIUM LIQUID | 100 MG / 5 ML | LIQUID | PHARMETICS (2011) INC | CANCELLED POST MARKET | DIN 02245845 |
| CALCIUM LIQUID | 112 MG | LIQUID | VITA HEALTH PRODUCTS INC | CANCELLED POST MARKET | DIN 00508640 |
| CALCIUM LIQUID | 132 MG | LIQUID | SHOPPERS DRUG MART INC. | CANCELLED POST MARKET | DIN 00548154 |
| CALCIUM LIQUID | 132 MG | LIQUID | KSL PHARMACEUTICALS | CANCELLED POST MARKET | DIN 01904469 |
| CALCIUM LIQUID SYRUP | 100 MG / 5 ML | SYRUP | SUPPLEMENTS AROMATIK INC. | CANCELLED POST MARKET | DIN 02246675 |
| CALCIUM SANDOZ FORTE 500MG | 2.94 G | TABLET (EFFERVESCENT) | SANDOZ CANADA INC | CANCELLED POST MARKET | DIN 00027588 |
Who else supplies CALCIUM (DIFFERENT SALTS IN COMBINATION) worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. CALCIUM (DIFFERENT SALTS IN COMBINATION) appears in 1674 registered pack listings across 11 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.